Carbamazepine Tablet, Extended Release
Product Images NDC 70518-3911

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Carbamazepine (NDC 70518-3911). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
This is a description for a medication called Carbamazepine Extended-Release 400 mg Tablet. It comes in a box containing 100 tablets. The medication should be protected from moisture. The label indicates that it is a prescription-only medication. The NDC number, expiration date, and lot number are also provided. The manufacturer of the medication is Cadista Pharma, Inc, located in Salisbury, MD. The storage instructions mention that it should be kept at a temperature of 20-25°C (58-77°F) with slight variations allowed. The medication has been repackaged by RemedyRepack Inc., located in Indiana, PA. It is important to keep this medication out of the reach of children, and it must be swallowed whole without crushing or chewing according to the warning. The package insert should be consulted for directions on usage.*
FDA Label Image

Mm2 (Carbamazepine 400mg 70518 3911 01)

Mm2 (Carbamazepine 400mg 70518 3911 01)
FDA Label Image

Image Description (Carbamazepine Structure)

Image Description (Carbamazepine Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.